GO
Loading...
 

The Flaws in Emerging Market Strategy

Tue 02 Apr 13 | 11:35 AM ET
 Highlight transcript below to create clip
Transcript:  Print  |  Email
    This term does not appear
Go
 Click text to jump within video

The Flaws in Emerging Market Strategy

Tue 02 Apr 13 | 11:35 AM ET
Andrew Weiss, head of pharma and biotech research at Vontobel, tells CNBC why Novartis' failure to win its battle for patent protection for the drug Glivec highlights the flaws in pharma companies' emerging market strategy.
 
RELATED ARTICLES AND CONTENT
More Videos
  • No Articles Available
Latest Videos
China is in a 'rut': Pro
Wed 23 Apr 14 | 04:10 AM ET
Latest Videos
Stocks: It's all about delivering earnings
Wed 23 Apr 14 | 04:00 AM ET
Latest Videos
Man United owners to blame for 'disaster': Pro
Wed 23 Apr 14 | 03:45 AM ET
Latest Videos
Some companies pretending to be tech stocks: Pro
Wed 23 Apr 14 | 03:20 AM ET
Go
Displaying results for: Latest Video | US